Temporary pacemakers are typically used for at least 24 hours before care teams consider implanting a permanent device. New research out of Canada suggests it may make sense in certain scenarios to go straight to the permanent pacemaker. 

Researchers expected these conditions to reduce the benefits of early treatment. However, that was not the case.

The European Society of Cardiology 2025 congress includes 10 Hot Line sessions and 28 late-breaking science sessions to showcase the latest science.

Alan Matsumoto, MD, chair of the American College of Radiology, explains ACR support for the Radiology Outpatient Ordering Transmission (ROOT) Act in Congress. 

Giving colchicine to patients prior to TAVR may reduce the risk of certain conduction disturbances, according to new research published in the Journal of the American Heart Association. It does not, however, improve survival.

Former ACC president Kim Allan Williams Sr., MD, shared his experience bringing helpful heart screenings to low-income neighborhoods. "You've got to be willing to go out and find where the patients are," he said. 

American Medical Association (AMA) Board of Trustees Member Scott Ferguson, MD, FACR, discusses how and why physicians are opting out of Medicare because the payments no longer are covering their costs. 

Researchers had thought 2-HOBA might reduce the risk of AFib recurrence after catheter ablation procedures. What they found, however, was that treatment with the compound was actually harmful for patients instead of helpful.